30
Participants
Start Date
January 12, 2022
Primary Completion Date
December 12, 2022
Study Completion Date
December 12, 2022
Famotidine 400 mg/50 mL
Administration of a suspension of famotidine, 0.5 mg/kg/12h (with a maximum dose of 80 mg/day, regardless of the patient's weight) during 29 days.
Necker - Enfants malades Hospital; Department of Pediatrics and Infectious Diseases, Paris
INSERM U 1163 - Laboratory of molecular mechanisms of hematologic disorders and therapeutic implications, Paris
UNKNOWN
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER